Amarantus submits orphan drug designation application to FDA for MANF
Amarantus announced it has applied to the FDA for Orphan Drug Designation for its investigational drug MANF (mesencephalic-astrocyte-derived neurotrophic factor) as treatment for retinal artery occlusion. December 19, 2014